Sun Pharma Advanced Research Company Limited

NSEI:SPARC Voorraadrapport

Marktkapitalisatie: ₹68.8b

Sun Pharma Advanced Research Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Anilkumar Raghavan

Algemeen directeur

₹69.6m

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO10.6yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn1.2yrs
Gemiddelde ambtstermijn bestuur7.5yrs

Recente managementupdates

Recent updates

Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans

Jan 17
Sun Pharma Advanced Research (NSE:SPARC) Is In A Good Position To Deliver On Growth Plans

Sun Pharma Advanced Research Company Limited's (NSE:SPARC) Business Is Trailing The Industry But Its Shares Aren't

Nov 14
Sun Pharma Advanced Research Company Limited's (NSE:SPARC) Business Is Trailing The Industry But Its Shares Aren't

Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?

Sep 05
Is Sun Pharma Advanced Research (NSE:SPARC) Using Too Much Debt?

Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation

Jun 27
Here's Why We're Not At All Concerned With Sun Pharma Advanced Research's (NSE:SPARC) Cash Burn Situation

Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?

Nov 23
Is Sun Pharma Advanced Research (NSE:SPARC) A Risky Investment?

If You Had Bought Sun Pharma Advanced Research's (NSE:SPARC) Shares Three Years Ago You Would Be Down 57%

Feb 08
If You Had Bought Sun Pharma Advanced Research's (NSE:SPARC) Shares Three Years Ago You Would Be Down 57%

Do Institutions Own Sun Pharma Advanced Research Company Limited (NSE:SPARC) Shares?

Dec 14
Do Institutions Own Sun Pharma Advanced Research Company Limited (NSE:SPARC) Shares?

CEO

Anilkumar Raghavan (56 yo)

10.6yrs

Tenure

₹69,608,000

Compensatie

Mr. Anilkumar Raghavan has been the Chief Executive Officer of Sun Pharma Advanced Research Company Limited since April 24, 2014. Mr. Raghavan is a senior pharmaceutical services executive with significant...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Anilkumar Raghavan
Chief Executive Officer10.6yrs₹69.61mgeen gegevens
Anup Rathi
Chief Financial Officerless than a yeargeen gegevensgeen gegevens
Nitin Dharmadhikari
Chief Operating Officerless than a yeargeen gegevensgeen gegevens
Jaydeep Issrani
Senior General Manager of Business Developmentno datageen gegevensgeen gegevens
Kajal Damania
Company Secretary & Compliance Officer1.2yrsgeen gegevensgeen gegevens
Shanta Gupta
Chief Human Resource Officer4.8yrsgeen gegevensgeen gegevens
Siu-Long Yao
Head Clinical Developmentless than a yeargeen gegevensgeen gegevens
Nitin Damle
Chief Innovation Officerno datageen gegevensgeen gegevens
Yashoraj Zala
Head of Drug Delivery Systemsno datageen gegevensgeen gegevens
Vikram Ramanathan
Head of Preclinical Development5.6yrsgeen gegevensgeen gegevens
Venkata Palle
Global Head of Drug Discovery & Preclinical Development1.7yrsgeen gegevensgeen gegevens
Shravanti Bhowmik
VP & Head Operations Managementless than a yeargeen gegevensgeen gegevens

1.2yrs

Gemiddelde duur

Ervaren management: Het managementteam van SPARC wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.2 jaar), wat duidt op een nieuw team.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Dilip Shanghvi
Chairman18.7yrs₹390.00k19.06%
₹ 13.1b
Robert Jay Spiegel
Independent Director4.4yrs₹630.00kgeen gegevens
Bhavna Doshi
Independent Director10.1yrs₹660.00kgeen gegevens
Thennati Rajamannar
Non-Executive Non-Independent Director17.4yrs₹300.00k0.011%
₹ 7.6m
Vidhi Shanghvi
Additional Non-Executive Non-Independent Directorless than a yeargeen gegevensgeen gegevens
Ferzaan Engineer
Independent Director7.5yrs₹630.00kgeen gegevens
Mark Simon
Member of Advisory Board3.9yrs₹570.00kgeen gegevens

7.5yrs

Gemiddelde duur

66yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van SPARC wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.5 jaar).